These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34177779)

  • 1. Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
    Picillo M; Ricciardi C; Tepedino MF; Abate F; Cuoco S; Carotenuto I; Erro R; Ricciardelli G; Russo M; Cesarelli M; Barone P; Amboni M
    Front Neurol; 2021; 12():674495. PubMed ID: 34177779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
    Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
    Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing.
    Nakahara K; Nakane S; Kitajima M; Masuda-Narita T; Matsuo H; Ando Y
    J Neurol; 2020 Mar; 267(3):752-759. PubMed ID: 31745723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes.
    Wattjes MP; Huppertz HJ; Mahmoudi N; Stöcklein S; Rogozinski S; Wegner F; Klietz M; Apostolova I; Levin J; Katzdobler S; Buhmann C; Quattrone A; Berding G; Brendel M; Barthel H; Sabri O; Höglinger G; Buchert R;
    Mov Disord; 2023 Oct; 38(10):1891-1900. PubMed ID: 37545102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W
    Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
    Picillo M; Cuoco S; Carotenuto I; Abate F; Erro R; Volpe G; Pellecchia MT; Catricalà E; Cappa S; Barone P
    PLoS One; 2019; 14(10):e0223621. PubMed ID: 31603934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
    Haggstrom L; Brew B; Sutton I; Tisch S
    J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of short-step and wide-based gait is a gait characteristic in progressive supranuclear palsy: a retrospective, cross-sectional study.
    Takamatsu Y; Matsuda N; Aiba I
    Eur Geriatr Med; 2019 Oct; 10(5):809-815. PubMed ID: 34652693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.
    Williams DR; Holton JL; Strand K; Revesz T; Lees AJ
    Mov Disord; 2007 Nov; 22(15):2235-41. PubMed ID: 17712855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.
    Campagnolo M; Weis L; Fogliano C; Cianci V; Garon M; Fiorenzato E; Carecchio M; Ferreri F; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2023 Feb; 130(2):97-109. PubMed ID: 36701008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Characterization of Cognitive Function in Typical and 'Brainstem Predominant'Progressive Supranuclear Palsy Phenotypes.
    Lee YC; Williams DR; Anderson JFI
    J Mov Disord; 2018 May; 11(2):72-77. PubMed ID: 29860785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.